CBC ran an interesting story on Aspirin's potential medical benefits in treating cancer and the lack of funding for a medical trial costing $10 million. Since Aspirin is off-patent, removing potential for profits, big pharmaceutical companies are not funding this medical trial. This story raises critical questions that shine the spotlight on cancer research charities.
If you find Charity Intelligence's research useful in your giving, please consider donating to support our work. Being entirely funded by donors like you maintains our independence and objectivity to help Canadians be informed in their giving. Canadians donate over $17 billion each year. This giving could achieve tremendous results. We hope Charity Intelligence's research helps Canadians give better.
The information in this report was prepared by Charity Intelligence Canada and its independent analysts from publicly-available information. Charity Intelligence and its analysts have made endeavours to ensure that the data in this report is accurate and complete but accepts no liability.
The views and opinions expressed are to inform donors in matters of public interest. Views and opinions are not intended to malign any religion, ethnic group, organization, individual or anyone or anything. Any dispute arising from your use of this website or viewing the material hereon shall be governed by the laws of the Province of Ontario, without regard to any conflict of law provisions.